Kristian Reich sold $2.9M of MoonLake Immunotherapeutics (MLTX)

Executed Jun 15, disclosed Jun 17, 2 days later.

Value, as filed

$2.9M

150,000 sh across 3 lots

Executed

Jun 15

the trade date, as filed

Disclosed

Jun 17

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kristian Reich Chief Scientific Officer profile →

Kristian Reich (Chief Scientific Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales, 1 filed past the two-business-day deadline), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $3.0M of MLTX (202,908 sh across 2 lots, as filed), executed Dec 8 2025.

The name

MLTX

MoonLake Immunotherapeutics MLTX · Healthcare · 18 filings in 24 months ticker →

Healthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kristian Reich in MLTX

MLTXSALE MoonLake Immunotherapeutics $1.0M
50,000 sh × $20.02
Exec Jul 21
Filed Jul 23 · 4:05 PM ET MLTXSALE MoonLake Immunotherapeutics $878K
43,700 sh × $20.09
Exec Jul 20
Filed Jul 21 · 6:13 PM ET MLTXSALE MoonLake Immunotherapeutics $322K
16,105 sh × $20.01
Exec Jul 15
Filed Jul 20 · 6:07 AM ET † MLTXSALE MoonLake Immunotherapeutics $3.0M
202,908 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET